SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-23-000424
Filing Date
2023-01-23
Accepted
2023-01-23 16:39:07
Documents
16
Period of Report
2023-01-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A hrmy-20230105x8ka.htm   iXBRL 8-K/A 47043
2 EX-10.1 hrmy-20230105xex10d1.htm EX-10.1 8079
3 GRAPHIC hrmy-20230105x8ka001.jpg GRAPHIC 1167
4 GRAPHIC hrmy-20230105xex10d1g001.jpg GRAPHIC 227777
5 GRAPHIC hrmy-20230105xex10d1g002.jpg GRAPHIC 194584
  Complete submission text file 0001558370-23-000424.txt   765344

Data Files

Seq Description Document Type Size
6 EX-101.SCH hrmy-20230105.xsd EX-101.SCH 3162
7 EX-101.LAB hrmy-20230105_lab.xml EX-101.LAB 15927
8 EX-101.PRE hrmy-20230105_pre.xml EX-101.PRE 10080
10 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20230105x8ka_htm.xml XML 4833
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39450 | Film No.: 23544917
SIC: 2834 Pharmaceutical Preparations